Merck 2Q FY26 net loss widens to $1.34 billion; sales rise 5% to $16.61 billion

Reuters2026/08/04 10:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Merck posted a GAAP net loss attributable to shareholders of USD 1.34 billion, or USD 0.54 per share, in 2Q26.
Net sales rose 5% to USD 16.61 billion from a year earlier, while GAAP other income swung to USD 99 million from an expense.
GAAP loss before taxes widened to USD 683 million from profit, as cost of sales climbed 24% to USD 4.4 billion.
On a non-GAAP basis, net loss narrowed to USD 330 million, or USD 0.13 per share, from GAAP results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Merck 2Q FY26 net loss widens to $1.34 billion; sales rise 5% to $16.61 billion

You may also like

Crypto prices